Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I
- 1 September 2004
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 83 (1-2) , 163-174
- https://doi.org/10.1016/j.ymgme.2004.07.003
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)The Journal of Pediatrics, 2004
- Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis IThe Lancet, 2003
- Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitroBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centresArchives of Disease in Childhood, 1997
- Long‐term outcome of Hurler syndrome following bone marrow transplantationAmerican Journal of Medical Genetics, 1993
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Cervical myelopathy due to dural compression in mucopolysaccharidosisSurgical Neurology, 1982
- Reversal of clinical features of hurler's disease and biochemical improvement after treatment by bone marrow transplantationJournal of Inherited Metabolic Disease, 1982
- REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATIONThe Lancet, 1981
- Communicating Hydrocephalus in Children with Genetic Inborn Errors of MetabolismPediatric Neurosurgery, 1975